Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $1.05 in the prior trading day, Acrivon Therapeutics Inc (NASDAQ: ACRV) closed at $1.11, up 5.71%. In other words, the price has increased by $5.71 from its previous closing price. On the day, 0.75 million shares were traded.
Ratios:
Our goal is to gain a better understanding of ACRV by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.17 and its Current Ratio is at 11.17. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Ladenburg Thalmann Upgraded its Neutral to Buy on September 16, 2024, while the target price for the stock was maintained at $16.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 30 ’25 when PERCEPTIVE ADVISORS LLC sold 437,881 shares for $1.41 per share. The transaction valued at 617,412 led to the insider holds 3,403,025 shares of the business.
PERCEPTIVE ADVISORS LLC sold 298,886 shares of ACRV for $400,507 on May 01 ’25. The 10% Owner now owns 3,104,139 shares after completing the transaction at $1.34 per share. On Apr 25 ’25, another insider, PERCEPTIVE ADVISORS LLC, who serves as the 10% Owner of the company, sold 1,054,669 shares for $1.95 each. As a result, the insider received 2,056,605 and left with 4,306,189 shares of the company.
Stock Price History:
Over the past 52 weeks, ACRV has reached a high of $10.16, while it has fallen to a 52-week low of $1.05. The 50-Day Moving Average of the stock is -36.39%, while the 200-Day Moving Average is calculated to be -80.21%.
Shares Statistics:
A total of 31.35M shares are outstanding, with a floating share count of 22.16M. Insiders hold about 29.34% of the company’s shares, while institutions hold 56.77% stake in the company.
